UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030781
Receipt number R000035146
Scientific Title Interview to medical doctors on their attitude towards integrative medicine
Date of disclosure of the study information 2018/01/12
Last modified on 2018/01/12 10:55:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Interview to medical doctors on their attitude towards integrative medicine

Acronym

Interview to doctors on IM

Scientific Title

Interview to medical doctors on their attitude towards integrative medicine

Scientific Title:Acronym

Interview to doctors on IM

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the attitudes and their backgrounds of medical doctors towards integrative medicine.

Basic objectives2

Others

Basic objectives -Others

To clarify the factors determining positive, intermediate, and negative attitudes.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the attitudes and their backgrounds of medical doctors towards integrative medicine.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Medical doctors working for Kanazawa Medical University
2) Those whom written informed consent can be obtained from
3) 3 doctors younger than 40 years old, 3 doctors older than 39 years old
4) 3males and 3 females
5) 6 from different department/specialty
6) 2 positive, 2 intermediate, and 2 negative attitude towards integrative medicine

Key exclusion criteria

Those whom written informed consent cannot be obtained from

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiharu Motoo

Organization

Kanazawa Medical Unversity

Division name

Department of Medical Oncology

Zip code


Address

1-1 Daigaku, Uchinada, Ishikawa 920-0293

TEL

076-286-2211

Email

motoo@kanazawa-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuho Hisamura

Organization

Kanazawa Medical Unversity

Division name

Department of Medical Oncology

Zip code


Address

1-1 Daigaku, Uchinada, Ishikawa 920-0293

TEL

076-286-2211

Homepage URL


Email

hisamura@kanazawa-med.ac.jp


Sponsor or person

Institute

Kanazawa Medical Unversity

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2018 Year 01 Month 10 Day

Date of IRB


Anticipated trial start date

2018 Year 01 Month 25 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Participants are asked questions according to prepared questionnaires.


Management information

Registered date

2018 Year 01 Month 12 Day

Last modified on

2018 Year 01 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035146


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name